Live
- NDA to fight Bihar polls with Nitish as CM face
- Allu Arjun refused to leave even after he was told of woman’s death
- Bareilly court summons Rahul Gandhi
- ‘Systematic conspiracy’ to undermine EC’s integrity: Kharge
- Popcorn tax slabs anger Congress
- India, Kuwait elevate ties to strategic level
- Nizamabad MP Dharmapuri Arvind and Jagtial MLA Dr. Sanjay Kumar Meet CM Revanth Reddy
- Hyderabad CP CV Anand Issues Stern Warning to Bouncers
- MP Laxman Criticizes Police Conduct, Calls for Support for Victims' Families
- Fire Breaks Out in Kachiguda-Chennai Egmore Express, Passengers Evacuated Safely
Natco settles patent litigation with Onyx
Highlights
City-based Natco Pharma on Thursday said it has settled a patent litigation with Onyx Therapeutics Inc in the US over a generic version of Kyprolis, an anti-cancer drug.
Hyderabad: City-based Natco Pharma on Thursday said it has settled a patent litigation with Onyx Therapeutics Inc in the US over a generic version of Kyprolis, an anti-cancer drug.
The company said it has reached a settlement agreement with Onyx Therapeutics Inc related to generic versions of 10mg, 30mg and 60mg of Kyprolis, Natco Pharma said in a regulatory filing.
Natco has tied up with Breckenridge Pharmaceutical Inc to market the product in the US.
Next Story
ADVERTISEMENT
